FindTrial
Sign In

How certain medicines that can harm the kidneys affect blood creatinine levels in children admitted to the hospital

Effect of Nephrotoxic Drugs on Serum Creatinine in Hospitalized Paediatric Patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/089447
Enrollment
200
Registered
2025-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R098- Other specified symptoms and signsinvolving the circulatory and respiratory systems

Interventions

Intervention1: Nil: Nil

Sponsors

Aakash Healthcare Super Specialty Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Paediatric patients aged less than 18 years NICU subgroup: neonates less than 28 days of life Exposure to one or more known nephrotoxic drugs Informed written consent obtained from parent/guardian

Exclusion criteria

Exclusion criteria: known case of pre-existing renal disease Azotemia at presentation. Known history of chronic kidney disease or congenital renal anomalies Previous renal transplant or dialysis Incomplete drug administration or creatinine monitoring data Parental refusal to consent

Design outcomes

Primary

MeasureTime frame
To study the incidence of drug induced AKI in hospitalised paediatric patients Timepoint: 30 months—

Secondary

MeasureTime frame
Incidence and staging of AKI as per KDIGO 2012 guidelines Time to rise in serum creatinine postdrug initiation Correlation between patient-related variables eg age, illness severity) and renal outcomes Timepoint: 30 months—

Countries

India

Contacts

Public ContactDr SYED MUSTAFA HASAN

Aakash Healthcare Super Specialty Hospital

drmustafa.hasan@aakashhealthcare.com9910447441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026